Cyclin D1 expression in multiple myeloma by immunohistochemistry: Case series of 14 patients and literature review

BACKGROUND: Cyclin D1 dysregulation is an early and unifying oncogenic event in patients of multiple myeloma (MM). This may be detected up to 30% cases by immunohistochemistry (IHC) and up to 40-50% cases by molecular studies. However, studies on the clinical significance of cyclin D1 dysregulation...

Descripción completa

Detalles Bibliográficos
Autores principales: Padhi, Somanath, Varghese, Renu G’Boy, Ramdas, Anita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3932597/
https://www.ncbi.nlm.nih.gov/pubmed/24604959
http://dx.doi.org/10.4103/0971-5851.125246

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3932597/
https://www.ncbi.nlm.nih.gov/pubmed/24604959
http://dx.doi.org/10.4103/0971-5851.125246

Ejemplares similares